| Epigenetic and Molecular Alterations in Obesity: Linking CRP and DNA Methylation to Systemic Inflammation C Cucoreanu, AB Tigu, M Nistor, RC Moldovan, IE Pralea, M Iacobescu, ... Current Issues in Molecular Biology 46 (7), 7430-7446, 2024 | | 2024 |
| Exploring Novel Frontiers in Cancer Therapy AB Tigu, C Tomuleasa Biomedicines 12 (6), 1345, 2024 | | 2024 |
| In vivo imaging system (IVIS) therapeutic assessment of tyrosine kinase inhibitor-loaded gold nanocarriers for acute myeloid leukemia: a pilot study RA Munteanu, AB Tigu, R Feder, AS Tatar, D Gulei, C Tomuleasa, S Boca Frontiers in Pharmacology 15, 1382399, 2024 | | 2024 |
| Differential effect of the duration of exposure on the carcinogenicity of cadmium in MCF10A mammary epithelial cells AA Zimta, D Cenariu, AB Tigu, C Moldovan, A Jurj, R Pirlog, C Pop, ... Food and Chemical Toxicology 186, 114523, 2024 | | 2024 |
| The carcinogenic capacity of arsenic in normal epithelial breast cells and double-positive breast cancer cells AA Zimta, D Cenariu, AB Tigu, C Moldovan, A Jurj, L Pop, ... Medicine and Pharmacy Reports 97 (2), 184, 2024 | | 2024 |
| Low-Dose Decitabine Plus Venetoclax As Frontline Treatment of Acute Myeloid Leukemia M Peters, C Jitaru, A Bancos, AB Tigu, D Cenariu, C Selicean, V Moisoiu, ... Transplantation and Cellular Therapy 30 (2), S113-S114, 2024 | | 2024 |
| Preclinical Evaluation of an Anti-CD41 CAR T Cell in Acute Megakaryoblastic Leukemia on in Vitro and In Vivo Models AB Tigu, C Constantinescu, P Teodorescu, D Kegyes, R Munteanu, ... Transplantation and Cellular Therapy 30 (2), S99, 2024 | | 2024 |
| The role of epigenetic modifier mutations in peripheral T-cell lymphomas AB Tigu, A Bancos Current Issues in Molecular Biology 45 (11), 8974-8988, 2023 | 2 | 2023 |
| Design and preclinical testing of an anti‐CD41 CAR T cell for the treatment of acute megakaryoblastic leukaemia AB Tigu, CS Constantinescu, P Teodorescu, D Kegyes, R Munteanu, ... Journal of Cellular and Molecular Medicine 27 (19), 2864-2875, 2023 | 1 | 2023 |
| Flow cytometry of CD5-positive hairy cell leukemia D Cenariu, I Rus, JT Bergthorsson, R Grewal, M Cenariu, V Greiff, AB Tigu, ... Molecular Diagnosis & Therapy 27 (5), 593-599, 2023 | 1 | 2023 |
| Hybrid Material Based on Vaccinium myrtillus L. Extract and Gold Nanoparticles Reduces Oxidative Stress and Inflammation in Hepatic Stellate Cells Exposed to … M Filip, I Baldea, L David, B Moldovan, GC Flontas, S Macavei, ... Biomolecules 13 (8), 1271, 2023 | 2 | 2023 |
| Optimization of tyrosine kinase inhibitor-loaded gold nanoparticles for stimuli-triggered antileukemic drug release AS Tatar, T Nagy-Simon, AB Tigu, C Tomuleasa, S Boca Journal of Functional Biomaterials 14 (8), 399, 2023 | 1 | 2023 |
| MDS cells maturation induced by ATRA differentiating agent in myelodysplastic syndromes. D Cenariu, AB Tigu, D Kegyes, M Peters, JT Bergthorsson, V Greiff, ... Studia Universitatis Babes-Bolyai, Historia Artium 68 (2), 2023 | | 2023 |
| RNA sequencing suggests that non‐coding RNAs play a role in the development of acquired haemophilia AB Tigu, I Hotea, R Drula, AA Zimta, N Dirzu, M Santa, C Constantinescu, ... Journal of Cellular and Molecular Medicine 27 (13), 1790-1796, 2023 | 1 | 2023 |
| The effect of different anesthetic techniques on proliferation, apoptosis, and gene expression in colon cancer cells: a pilot in vitro study AL Alexa, A Jurj, C Tomuleasa, AB Tigu, RM Hategan, D Ionescu Current Issues in Molecular Biology 45 (1), 738-751, 2023 | 2 | 2023 |
| Low-Molecular-Weight Heparins (LMWH) and Synthetic Factor X Inhibitors Can Impair the Osseointegration Process of a Titanium Implant in an Interventional Animal Study D Apostu, B Berechet, D Oltean-Dan, A Mester, B Petrushev, C Popa, ... Medicina 58 (11), 1590, 2022 | | 2022 |
| Hybrid Lipid Nanoformulations for Hepatoma Therapy: Sorafenib Loaded Nanoliposomes—A Preliminary Study A Bartos, I Iancu, L Ciobanu, A Onaciu, C Moldovan, A Moldovan, ... Nanomaterials 12 (16), 2833, 2022 | 5 | 2022 |
| Alendronate Prevents Early Periprosthetic Bone Loss in Cementless Total Hip Arthroplasty Better Than Simvastatin D Apostu, D Oltean-Dan, A Mester, A Maxim, AB Tigu, HRC Benea, ... Applied Sciences 12 (16), 8054, 2022 | | 2022 |
| Phytochemicals as regulators of tumor glycolysis and hypoxia signaling pathways: evidence from in vitro studies IE Pralea, AM Petrache, AB Tigu, D Gulei, RC Moldovan, M Ilieș, ... Pharmaceuticals 15 (7), 808, 2022 | 7 | 2022 |
| Natural compounds modulate the crosstalk between apoptosis-and autophagy-regulated signaling pathways: Controlling the uncontrolled expansion of tumor cells C Braicu, O Zanoaga, AA Zimta, AB Tigu, KL Kilpatrick, A Bishayee, ... Seminars in Cancer Biology 80, 218-236, 2022 | 63 | 2022 |
